Artigo Acesso aberto Revisado por pares

Plasma HIV-1 RNA Detection Below 50 Copies/mL and Risk of Virologic Rebound in Patients Receiving Highly Active Antiretroviral Therapy

2012; Oxford University Press; Volume: 54; Issue: 5 Linguagem: Inglês

10.1093/cid/cir936

ISSN

1537-6591

Autores

Tracey M. Doyle, Colette Smith, Paola Vitiello, Valentina Cambiano, Melanie Johnson, Andrew Owen, Andrew Phillips, Anna María Geretti,

Tópico(s)

HIV/AIDS Research and Interventions

Resumo

Background. Plasma human immunodeficiency virus type 1 (HIV-1) RNA suppression <50 copies/mL is regarded as the optimal outcome of highly active antiretroviral therapy (HAART). Current viral load (VL) assays show increased sensitivity, but the significance of RNA detection <50 copies/mL is unclear.

Referência(s)